Quality indicators and specifications for the extra-analytical phases in clinical laboratory management
-
Carmen Ricós
Abstract
Background: Quality management systems should cover all the steps involved in the overall testing and non-testing processes.
Aim: To identify quality indicators for extra-analytical processes in the clinical laboratory and to specify acceptability limits, in order to provide a useful tool for continuous improvement of laboratory service.
Methods: A literature review by Medline search was performed using the keywords: Q-Tracks and Q-probes alone, and management, error, mistake, and indicator crossed with quality, laboratory and medicine. The indicators retrieved were organized according to the various laboratory processes. Their expression was standardized in relation to the total activity of each process reported in each paper reviewed. The magnitude of the errors reported was considered to be the current state of the art for the extra-analytical step and was proposed as the quality specification.
Results: Examples of indicators and specifications for the pre-analytical process:
Analytical request: Error in patient identification (0.08%), request unintelligible (0.1%).
Sampling: Requested but not collected (7%), redraws (2%).
Transport and reception of samples: Inadequate transportation conditions (0.005%), hemolyzed sample (0.2%).
Examples of indicators and specifications for the post-analytical process:
Analytical request: Error in patient identification (0.08%), request unintelligible (0.1%).
Sampling: Requested but not collected (7%), redraws (2%).
Transport and reception of samples: Inadequate transportation conditions (0.005%), hemolyzed sample (0.2%).
Report validation: Test not performed (1.4%), test performed but not requested (1.1%).
Intra-laboratory reports: Laboratory reporting errors (0.05%), delivery outside specified time (11%).
Consulting service: average time to communicate critical values for inpatients (6 min).
Conclusions: These extra-analytical indicators and their specifications, expressed in a standardized manner, constitute a preliminary basis for comparison of individual laboratory performance with the purpose of improving laboratory quality.
Copyright © 2004 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Publishers note
- Towards quality specifications in extra-analytical phases of laboratory activity
- Quality indicators and specifications for the extra-analytical phases in clinical laboratory management
- Pitfalls and drawbacks in screening of congenital disorders of glycosylation
- Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
- Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas
- Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
- Neurokinin B levels in maternal circulation during early pregnancy
- Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation
- Urine labeling with orally applied marker substances in drug substitution therapy
- Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
- Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms
- Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls
- Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease
- Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)
- The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization
- First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B
- Myeloma cells produce sialyl salivary-type amylase
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
- Meetings and Awards
Articles in the same Issue
- Publishers note
- Towards quality specifications in extra-analytical phases of laboratory activity
- Quality indicators and specifications for the extra-analytical phases in clinical laboratory management
- Pitfalls and drawbacks in screening of congenital disorders of glycosylation
- Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
- Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas
- Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
- Neurokinin B levels in maternal circulation during early pregnancy
- Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation
- Urine labeling with orally applied marker substances in drug substitution therapy
- Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
- Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms
- Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls
- Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease
- Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)
- The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization
- First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B
- Myeloma cells produce sialyl salivary-type amylase
- Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
- Meetings and Awards
